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TRPC5 ion channel permeation 
promotes weight gain in 
hypercholesterolaemic mice
Baptiste Rode, Nadira Y. Yuldasheva, Paul D. Baxter, Alicia Sedo, Justin F. Ainscough  , 
Michael Shires  , Mark T. Kearney, Marc A. Bailey, Stephen B. Wheatcroft & David J. Beech  
Transient Receptor Potential Canonical 5 (TRPC5) is a subunit of a Ca2+-permeable non-selective 
cationic channel which negatively regulates adiponectin but not leptin in mice fed chow diet. 
Adiponectin is a major anti-inflammatory mediator and so we hypothesized an effect of TRPC5 on 
the inflammatory condition of atherosclerosis. Atherosclerosis was studied in aorta of ApoE−/− mice 
fed western-style diet. Inhibition of TRPC5 ion permeation was achieved by conditional transgenic 
expression of a dominant negative ion pore mutant of TRPC5 (DNT5). Gene expression analysis in 
adipose tissue suggested that DNT5 increases transcript expression for adiponectin while decreasing 
transcript expression of the inflammatory mediator Tnfα and potentially decreasing Il6, Il1β and Ccl2. 
Despite these differences there was mild or no reduction in plaque coverage in the aorta. Unexpectedly 
DNT5 caused highly significant reduction in body weight gain and reduced adipocyte size after 6 and 
12 weeks of western-style diet. Steatosis and circulating lipids were unaffected but mild effects on 
regulators of lipogenesis could not be excluded, as indicated by small reductions in the expression of 
Srebp1c, Acaca, Scd1. The data suggest that TRPC5 ion channel permeation has little or no effect on 
atherosclerosis or steatosis but an unexpected major effect on weight gain.
Mammalian Transient Receptor Potential (TRP) proteins are encoded by 28 widely-expressed genes1. They cluster 
together to form tetrameric ion channels with central ion pores which confer membrane permeability to mon-
ovalent cations including Na+ and usually the divalent cation Ca2+ 2–4. The tetramers are either homomers or 
heteromers in which at least one TRP protein is different2.
Transient Receptor Potential Canonical 5 (TRPC5) is from the subset of TRP proteins most related to the arche-
typal D melanogaster TRP protein, hence “canonical”2,5–8. It was first recognised in 1998 and indicated primarily 
as a protein of the central nervous system9, yet subsequent studies suggested expression and function in a range of 
tissue and cell types including renal podocytes, vascular smooth muscle cells, endothelial cells and monocytes10–12. 
Its importance in various disease states has been suggested, including depression and kidney disease13,14.
In 2012 we reported that TRPC5 is expressed in adipocytes of perivascular fat from patients undergoing cor-
onary artery bypass surgery15. We suggested that it generated a constitutively-active channel in heteromers with 
TRPC1 to permit Ca2+ entry into adipocytes, with the downstream consequence of suppressing the generation of 
adiponectin15, a key anti-inflammatory adipokine16,17. By mutating an amino acid triplet in TRPC5 which deter-
mines ion permeation, we created a dominant negative form of the protein that inhibited Ca2+ influx through 
the channels (DNT5). Conditional expression of DNT5 from a transgene in mice elevated plasma adiponectin, 
consistent with the idea that the channels suppressed adiponectin. Through an in vitro screen of lipids, ω-3 fatty 
acids were revealed as inhibitors of the channel. When fat was excised from mice expressing DNT5, ω-3 fatty 
acids had lost their capability to enhance the release of adiponectin, suggesting a mechanism dependent on Ca2+ 
permeation through TRPC5 channels15. There were apparently no deleterious effects of expressing DNT5. Overall 
the data suggested that TRPC5 is part of a Ca2+ entry mechanism in adipocytes which is important for the control 
of the generation or release of adiponectin.
Because adiponectin is a dominant anti-inflammatory mediator, we hypothesized that Ca2+ entry through 
TRPC5 channels might be important in inflammatory diseases such as atherosclerosis. To investigate this hypoth-
esis we transferred DNT5 to a mouse model in which atherosclerosis is accelerated by a combination of ApoE 
gene disruption and western-style diet to elevate plasma cholesterol.
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Results
Expression of DNT5 was controlled by the doxycycline (DOX) inducible TET-ON system illustrated in Fig. 1A. 
All experiments were on ApoE−/− male mice on western-style diet from the age of 8 weeks (Fig. 1B). Expression 
of DNT5 in adipose tissue and liver was detected after induction with DOX (Fig. 1C,D; Supplementary 
File 1). For every parameter of the present study, observation of values for each genotype did not reveal obvi-
ous single-transgene effects (Supplementary File 2). Therefore non-transgenics and single-transgenics were 
pooled in the Control group as previously15. Data were analysed using two different statistical approaches: (1) a 
Mann-Whitney test comparing the two groups of mouse regardless of the influence of a cage; (2) a linear random 
effects model considering each cage as a single experiment to enable detection of small effects potentially aliased 
with cage (see Methods).
Figure 1. Expression of DNT5 in hypercholesterolaemic mice. (A) Schematic of the transgenes regulating the 
expression of DNT5. DNT5 coding sequence was placed under the control of a Tetracycline Response Element 
(TRE) that co-regulated the expression of a LacZ reporter. Expression was dependent on the expression of a 
transactivator (rtTA) from the ROSA26 locus that conferred putatively global expression regulated in a time-
controlled manner by addition of doxycycline (DOX) in the drinking water. Only mice with both transgenes 
expressed DNT5 and were referred as DNT5; non-and single-transgenic mice were the Controls. (B) Control 
and DNT5-expressing mice on ApoE−/− background were kept on standard chow diet and did not express DNT5 
until 8 weeks of age. During the treatment phase (12 weeks), chow diet was replaced with western-style diet 
and DOX was given to mice of the two groups, triggering the expression of DNT5 in DNT5 group but not in 
Controls. All data were from mice which had been provided with western-style diet and DOX for 12 weeks.  
(C) Gel-electrophoresis of end-point RT-PCR performed on epididymial fat pad (left) and liver (right). Results 
are shown without (−) and with (+) reverse transcription (RT). The sizes of the DNA markers is indicated on the 
left in base-pairs. The arrows point to the expected PCR product sizes. DNT5 mRNA was detected in tissues from 
DOX-treated double transgenic mice but not Controls. Gels were cropped for presentation purposes. Full length 
gels are presented in Supplementary File 1. (D) Real-time PCR analysis of the expression of DNT5 mRNA in the 
epididymal fat pad (N = 9) and liver (N = 14) of DOX-treated double transgenic mice (DNT5 group).
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Reduced markers of inflammation in adipose tissue. In line with prior observations on adiponec-
tin and leptin proteins15 there was elevated adiponectin transcript in the DNT5 group and no change in leptin 
(Fig. 2A). Consistent with elevated adiponectin, there was reduced abundance of transcript encoding the key 
inflammatory mediator including tumour necrosis factor α (Tnfα) and potentially small reductions in interleukin 
6 (Il6), interleukin 1β (Il1β) and C-C motif chemokine ligand 2 (Ccl2) (Fig. 2B). The reduction in Il6, Il1β and 
Ccl2 abundance was statistically significant only when using the linear random effect model, suggesting subtle 
effect. There was not a general effect on all mediators because expression of C-C motif chemokine ligands 3, 5 and 
7 (Ccl3, Ccl5 and Ccl7) was unaffected (Fig. 2B). The data suggested that DNT5 positively impacted adiponectin 
gene expression and negatively impacted expression of some but not all key pro-inflammatory mediators.
Figure 2. Increased adiponectin and reduced inflammatory gene expression in adipose tissue of DNT5 mice. 
All data were from quantitative real-time PCR analysis of epididymal fat pad RNA after mice had been provided 
with western-style diet and DOX for 12 weeks. All mice were ApoE−/−. (A) Comparison of adiponectin 
(AdipoQ) and leptin (Lep) mRNA abundance between Controls and DNT5. On the left, Mann-Whitney 
analysis showing mean and s.e.m (N = 10 Control, N = 14 DNT5). On the right, linear random effects model 
analysis showing the standardised mean difference and confidence intervals (n/N = 8/10 Control, n/N = 8/14 
DNT5). Data above the zero line indicate increase in the DNT5 group. (B) Comparison of the inflammatory 
mediators tumour necrosis factor α (Tnfα), interleukin 6 (Il6), interleukin 1β (Il1β) and C-C motif chemokine 
ligands 2, 3, 5 and 7 (Ccl2, 3, 5 and 7) mRNA abundance between Controls and DNT5. On the left, Mann-
Whitney analysis showing mean and s.e.m (N = 10 Control, N = 14 DNT5). On the right, linear random effects 
model analysis showing the standardised mean difference and confidence intervals. Data below the zero line 
indicate decrease in the DNT5 group (n/N = 8/10 Control, n/N = 8/14 DNT5).
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Mild or no effect on atherosclerosis. With reciprocal effects of DNT5 on adiponectin and some inflam-
matory mediators it was anticipated that there may be suppression of atherosclerosis. We quantified plaque cover-
age in the aorta at the 12-week time point after staining of lipid deposits with Oil Red O (Fig. 3A). Analysis of the 
whole aorta including the aortic arch did not reveal significant effect of DNT5 but focussed analysis of the aortic 
conduit suggested that there may have been a small reduction in plaque coverage (Fig. 3A,B). Therefore DNT5 
had no major effect on atherosclerosis in the aorta, aside perhaps for a mild region-specific effect.
Marked reduction in weight gain. Body weight was measured at 0-, 6- and 12-week time points (Fig. 4A). 
Mice in both groups appeared in similar health and gained weight. However the DNT5 group unexpectedly 
displayed lower body weight gain as compared to Controls at both 6- and 12-week time points (Fig. 4A,B). 
Histological analysis of adipocytes in fat pads revealed that adipocytes were significantly smaller in the DNT5 
group (Fig. 5A,B). The data suggested that DNT5 protected against increase in body weight and adipocyte size.
No effect on steatosis and mild or no effect on lipogenesis regulators. Because of the effect on 
adiposity we analysed the liver to determine the relevance to steatosis (fatty liver). Histological analysis of the 
liver suggested no effect of DNT5 on steatosis (Fig. 6A,B). To investigate whether there might be other effects 
on the liver, we quantified the expression of a key determinant of lipogenesis, sterol regulatory element-binding 
protein 1c (Srebp1c). The expression of this gene was significantly reduced in the DNT5 group when analysed 
with the linear random effects model (Fig. 6C). To further explore this effect we investigated the expression of a 
gene downstream of Srebp1c, the gene encoding acetyl-CoA carboxylase 1 (Acaca) and the fatty acid synthase 
(Fasn) and the stearoyl-CoA desaturase 1 (Scd1). Expression of Acaca and Scd1 was less in the DNT5 group when 
using the linear random effects model and the Mann-Whitney test, respectively, consistent with down-regulated 
Srebp1c gene expression (Fig. 6C). Gene expression of Fasn was not significantly affected (Fig. 6C). Plasma con-
centrations of cholesterol, high- and low-density lipoproteins (HDL and LDL) and triglycerides were not changed 
(Fig. 6D). The data suggested that DNT5 had mild effects on hepatic expression of regulators of lipid metabolism 
but lacked effect on steatosis or plasma lipids.
Discussion
This study primarily reveals an unexpected positive effect of TRPC5 ion permeation on body weight gain and 
adipocyte expansion. Consistent with prior work, there was an effect on adiponectin gene expression but changes 
in the expression of pro-inflammatory mediators were mostly restricted to an effect on Tnfα. Atherosclerosis in 
the aorta was largely unaffected. A mild effect on hepatic lipogenesis gene expression was apparent but there were 
no changes in steatosis or plasma lipids.
We analysed our data using two statistical approaches. The Mann-Whitney testing provided global analysis of 
the two groups of mice and was similar to the approach used in most published studies of this type. This approach 
allowed us to identify some effects of DNT5 but precluded the observation of effects which were small in size or 
Figure 3. Mild or no effect on atheroma in DNT5 aortic conduit. All data were from mice which had been 
provided with western-style diet and DOX for 12 weeks. All mice were ApoE−/−. (A) Example aortae from the 
heart to the iliac bifurcation, opened, and stained with Oil Red O. Scale bar 2 mm. (B) Comparison of Oil Red 
O percentage coverage (Atherosclerosis) between Controls and DNT5 in the whole aorta, aortic arch and aortic 
conduit as specified in (A). On the left, Mann-Whitney analysis showing mean and s.e.m (N = 13 Control, 
N = 16 DNT5). On the right, linear random effects model analysis showing the standardised mean difference 
and confidence intervals. Data below the zero line indicate decrease in the DNT5 group (n/N = 10/13 Control, 
n/N = 10/16 DNT5).
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had high variability. We therefore performed additional analysis by considering each cage of mice as an individ-
ual experiment using a linear random effect model. This approach is justified by the fact that behaviour varies 
from one mouse cage to another, making each cage an individual entity. As expected, differences detected by the 
Mann-Whitney test (adiponectin and Tnfα gene expression, body weight gain and adipocyte expansion) were 
also detected by the linear random effect model and are likely to be strongly dependent on TRPC5 channels. Only 
the hepatic expression of Scd1 was significantly different with the Mann-Whitney test, suggesting this parameter 
is less dependent on the cage effect. The linear random effect model allowed us to pinpoint other possible effects 
of DNT5 (adipose tissue expression of Il6, Il1β, Ccl2, atherosclerosis in the artic conduit, hepatic expression of 
Srebp1c and Acaca). The fact that these parameters show significant difference only with the linear random effect 
model suggests that they are less dependent on TRPC5 channels or the role of TRPC5 channels might vary from 
one individual to another, but could contribute to a global beneficial effect of a TRPC5 channel targeting strategy.
DNT5 was conditionally expressed and predicted to achieve effect by incorporating into native channels as 
they assemble from natively expressed proteins, attenuating the ion permeation in these channels. TRPC5 assem-
bles with TRPC1 and its close relative TRPC43,18–20. Therefore we assume that DNT5 inhibited ion permeation 
through native channels which involved TRPC1 and TRPC5, the channel suggested to be functionally significant 
in adipocytes15. DNT5 indeed inhibited native TRPC1/TRPC5 heteromers21 and to the best of our knowledge 
there is no evidence for other interactions: DNT5 had no effect on two other TRP channels (TRPM2 and TRPM3) 
or KV voltage-gated potassium channels which are distantly related to TRPC channels and which assemble simi-
larly as tetramers15. Therefore DNT5 has specificity and it is likely that the natural biological rules of these chan-
nels ensure specificity.
We previously demonstrated that TRPC5 has a negative effect on adiponectin protein secretion by using 
DNT5, anti-TRPC5 blocking antibody and linoleic acid (a natural inhibitory of TRPC1/TRPC5 channels), in 
3T3-adipocytes and adipose tissue15. Here, we provide further information by showing that the effect occurs at 
Figure 4. Reduced weight gain in DNT5 mice. All data were from mice which had been provided with western-
style diet and DOX for 12 weeks. All mice were ApoE−/−. (A) Body weight of mice from the time of starting 
western-style diet and DOX treatment at 8 weeks of age Mann-Whitney analysis showing mean and s.e.m 
(N = 10 Control, N = 13 DNT5). (B) Comparison of weight gain between Controls and DNT5. On the left, 
Mann-Whitney analysis showing mean and s.e.m (N = 10 Control, N = 13 DNT5). On the right, linear random 
effects model showing the standardised mean difference and confidence intervals. Data below the zero line 
indicate reduction in the DNT5 group (n/N = 7/10 Control, n/N = 7/13 DNT5).
Figure 5. Reduced adipocyte size in DNT5 mice. All data were from mice which had been provided with 
western-style diet and DOX for 12 weeks. All mice were ApoE−/−. (A) Example of epididymal fat pad sections 
taken after 12 weeks of treatment and stained with H&E. Scale bar 100 μm. (B) Comparison of adipocyte size 
between Controls and DNT5. On the left, Mann-Whitney analysis showing mean and s.e.m (N = 11 Control, 
N = 14 DNT5). On the right, linear random effects model showing the standardised mean difference and 
confidence intervals. Data below the zero line indicate reduction in the DNT5 group (n/N = 8/11 Control, 
n/N = 8/14 DNT5).
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Figure 6. Reduced hepatic gene expression for lipogenesis mediators in DNT5 mice. All data were from mice 
which had been provided with western-style diet and DOX for 12 weeks. All mice were ApoE−/−. (A) Example 
liver sections stained with H&E. Scale bar 100 μm. (B) Comparison of lipid content (steatosis) between Controls 
and DNT5. On the left, Mann-Whitney analysis showing mean and s.e.m (N = 11 Control, N = 14 DNT5). On 
the right, linear random effects model showing the standardised mean difference and confidence intervals. 
Data below the zero line indicate decrease in the DNT5 group (n/N = 8/11 Control, n/N = 8/13 DNT5). (C) All 
data were from quantitative real-time PCR analysis of liver RNA. Comparison of expression of sterol regulatory 
element-binding protein 1c gene (Srebp1c), acetyl-CoA carboxylase 1 gene (Acaca), fatty acid synthase gene 
(Fasn) and stearoyl-CoA desaturase 1 gene (Scd1) mRNA abundance between Controls and DNT5. On the left, 
Mann-Whitney analysis showing mean and s.e.m (N = 11 Control, N = 14 DNT5). On the right linear random 
effects model showing the standardised mean difference and confidence intervals. Data below the zero line 
indicate decrease in the DNT5 group (n/N = 8/11 Control, n/N = 8/13 DNT5). (D) Comparison of non-fasting 
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the RNA level, suggesting a transcriptional effect or an effect on RNA stability. This effect could be explained by 
Ca2+-dependent regulation of adiponectin gene expression because a Ca2+-sensitive transcription factor, namely 
the nuclear factor of activated T-cells c4 (Nfatc4), was previously shown to be a negative regulator of adiponectin 
gene expression22. TRPC proteins form non-selective cationic channels that also allow Na+ and K+ flux with 
possible impact on the membrane potential2. It is therefore likely that inhibition of TRPC5 channel permeation 
has complex consequences due to effects on surrounding voltage-dependent channels in adipocytes but also 
throughout the body, including the vasculature and the central nervous system.
There are limitations of ApoE−/− mice as a model of patients with coronary artery disease: apart from the hae-
modynamic differences between human and mouse, the hypercholesterolemia is severe and the time for plaque 
development is short. These mice are however extensively used as a first step to determining relevance in human. 
In the case of our study, the mice did not develop strongly abundant atherosclerosis as is normally seen because 
the mice needed to be continuously exposed to DOX, which has anti-atherosclerotic effect23,24. We could therefore 
test for an effect of DNT5, but against a smaller atherosclerotic signal than we ordinarily observe in ApoE−/− 
mice. Nevertheless, atherosclerosis was observed and Control and DNT5 mice received the same DOX, so they 
both had this background of partial protection against atherosclerosis. This effect is unlikely to be dependent on 
cholesterol handling as we did not observe difference in circulating levels of cholesterol between the two groups 
of mice. However, the reduction in inflammation we observe might be beneficial. Plaque formation is complex 
and other factors such as shear stress and endothelial dysfunction might also have been affected by TRPC5 chan-
nels. If there is motivation to further investigate the relationship of TRPC5 to atherosclerosis, alternative genetic 
approaches would be needed to circumvent the DOX limitation. Alternative models of atherosclerosis could also 
be explored along with aortic sinus inspection and detailed characterisation of plaque structure.
We considered whether elevated adiponectin expression could explain all or most of the phenotypic changes 
in the DNT5 group. Reduced adipose tissue inflammation, hepatic Srebp1c expression and atherosclerosis would 
be consistent with elevated adiponectin25–27. However, as we have indicated, some of these effects were mild at best 
and the effect on inflammation was more specific on Tnfα than might be expected for an adiponectin-mediated 
phenomenon. Importantly, improvement in glucose homeostasis might arise from inhibition TRPC5 channels as 
elevation in adiponectin is known to improve insulin sensitivity and glucose tolerance. Continuous administra-
tion of sucrose along with DOX in our model might preclude the study of glucose homeostasis in our model but 
further investigation of the effect of TRPC5 channel inhibition in diabetic models may answer these questions.
It is unclear if the reduced weight gain and reduced adipocyte expansion could be explained by elevated adi-
ponectin. Mice over-expressing adiponectin were found to have lower body weight in models of diet-induced 
obesity28,29 but increased expression of adiponectin in ob/ob mice promoted body weight gain30 and adiponectin 
knockout mice had lower body weight gain when fed with high fat diet31. The finding of DNT5’s protective effect 
against weight gain is also superficially contradictory to the finding that neuronal pro-opiomelanocortin-specific 
disruption of TRPC5 in mice decreased energy expenditure and increased food intake, resulting in elevated body 
weight32. Important differences between the studies could explain the different outcomes, including the genetic 
background of our mice, the diet and the different technical strategies for interfering with the TRPC5 chan-
nels. Trpc5 knockout mice were found to be protected against hepatomegaly and liver dysfunction in a model of 
diet-induced cholestasis33 and Trpc1 knockout mice were protected against high fat diet-induced body weight 
gain34. These findings support the idea that the TRPC5/TRPC1 type of ion channel may exacerbate adverse effects 
in metabolic disorders. We observed an effect on hepatic lipogenesis genes but it was mild, with only a small 
reduction in expression and not all the genes being affected. This effect could potentially contribute to reduced 
body weight gain and adipocyte size but is unlikely to be a major contributor of the striking effect on body weight. 
It is important to note that we used a conditional expression of dominant negative mutant to inhibit the channels 
which is probably less efficient in inhibiting the channel in vivo than a gene knockout but perhaps more likely 
to be closer to a drug-based strategy. Lipid metabolism might be affected by TRPC5 channels in adipocytes and 
this might vary from one fad pad to another. Detailed study of lipid handling in abdominal, subcutaneous and 
perivascular fat, along with brown adipose tissue might help to understand the role of TRPC5 channels in fat 
accumulation and body weight regulation. It will be important to investigate the mechanisms of the effects on 
body weight and adipocyte size, including whether global TRPC5 disruption affects food intake, excretion or 
metabolic rate and whether the effect is mediated peripherally or via the central nervous system. Krout and al 
have suggested that Trpc1 knockout mice have reduced food intake34 and we have shown that TRPC1/5 channels 
have physiological function in adipocytes15, suggesting multiple roles of TRPC channels in body weight regula-
tion. Despite the mechanism being unknown, our observation of significant reduction in body weight without 
obvious adverse effect indicates that targeting TRPC5 channels is a potential way to reduce obesity in the context 
of hypercholesterolaemia.
From a therapeutic perspective the data suggest that inhibitors of TRPC5 channels might beneficially protect 
against weight gain and potentially have other helpful effects which include reduced adipose tissue inflammation. 
The study encourages further investigation of the role of these ion channels in weight gain and inflammation and 
supports the development of new pharmacology for these channels. An important next step forward is the iden-
tification of a specific small-molecule inhibitor of the channels which could be administered effectively in vivo in 
plasma concentrations of cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) and 
triglycerides between Controls and DNT5 after 12 weeks of western-style diet and DOX administration. On 
the left, Mann-Whitney analysis showing mean and s.e.m (N = 11 Control, N = 14 DNT5). On the right, linear 
random effects model showing the standardised mean difference and confidence intervals (n/N = 8/11 Control, 
n/N = 8/14 DNT5).
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mice and other species. After initial limited progress towards such inhibitors35, highly potent and specific agents 
are emerging13,14,36. It will be interesting to investigate if inhibitors of this type are protective in cardiovascular 
and metabolic disease models and if they lack significant unwanted effects on other parameters, which Trpc5 
knockout mouse studies have suggested might occur on joint inflammation37 and possibly on blood pressure38,39.
Methods
Ethical approval. All procedures were approved by the University of Leeds Ethical Review Committee 
and conducted under UK Home Office licence in accordance with the requirements of the Animals (Scientific 
Procedures) Act 1986 (UK).
Transgenic mice. Conditional expression of dominant negative ion pore mutant of TRPC5 (DNT5) in 
mice has been described previously15. Briefly, DNT5 cDNA cloned into the pTRE vector from Clontech was 
expressed dependent on doxycycline (DOX) regulation of an additional co-expressed transgene encoding reverse 
tetracycline DOX-regulated transactivator (rtTA) from the ROSA26 locus, designed to confer broad expres-
sion across multiple cell types. These mice were crossed with mice homozygous for disruption of ApoE (Charles 
River, Belgium) so that all mice were ApoE−/−. Primers used for genotyping primer are specified in Table 1. Only 
male mice were used for experiments. From 8-weeks of age the food for all mice was changed from chow to 
western-style diet for the next 12 weeks. The diet contained 21% fat from lard supplemented with 0.15% wt/
wt cholesterol (#829100, SDS, Witham, Essex, UK). At the same time, all mice received 0.5 mg/mL DOX in the 
drinking water, sweetened with 2% sucrose. Single transgenics and non-transgenic litter-mates used as Controls 
also received DOX. Detailed results for each genotype are given in Supplementary File 2. As expected, DOX 
induced DNT5 expression only in double transgenics.
Tissue collection. Tissue was collected under terminal anaesthesia. Epididymal fat pads and liver were snap 
frozen on liquid nitrogen and stored at −80 °C. Mice were then perfusion-fixed with phosphate-buffered para-
formaldehyde (4% wt/vol, pH 7.2). The entire aortic tree was dissected free of fat and other tissue.
RNA isolation and real-time RT-PCR. Total RNA was isolated using a standard TriReagent protocol and 
treated with DNAse (TURBO DNA-free, AM1907M, Ambion). An aliquot was used for cDNA synthesis using a 
High Capacity RNA-to-cDNA kit (Applied Biosystems, UK) containing Oligo-dT and random primers. Real-time 
PCR was performed using Roche Fast Start SYBR Green I on a Lightcycler2 with Lightcycler 3.5 software or using 
Roche 480 SYBR Green I on a Lightcycler480II with Lightcycler 1.5.62 software. DNA amplification was for 35 
cycles with an initial 10 min at 95 °C followed by 10 s at 95 °C, 6 s at 55 °C, and 14 s at 72 °C. Primers were used at 
0.5 μmole/L. Sequences of PCR primer are specified in Table 1. The specificity of PCR was verified by reactions 
without RT (-RT) and by melt-curve analysis. PCR cycle crossing-points (CP) were determined by fit-points 
methodology. Relative abundance of target RNA was calculated from (E18SCp)/(EtargetCp). PCR products were elec-
trophoresed on 2% agarose gels containing ethidium bromide. All quantitative PCR reactions were performed in 
duplicate and the data averaged to generate one value per experiment. On Fig. 1D, data are presented as Relative 
abundance. On Figs 2–6, data are presented after normalization to the Control group mean value.
Gene Application Forward primer sequence (5′ to 3′) Reverse primer sequence (5′ to 3′)
Product size 
(base pairs)
LacZ Genotyping AATGGTCTGCTGCTGCTGAAC GGCTTCATCCACCACATACAG 225
rtTA Genotyping TTTCGATCTGGACATGTTGGG GGCATCGGTAAACATCTGCTC 184
ApoE-WT Genotyping GCCTAGCCGAGGGAGAGCCG TGTGACTTGGGAGCTCTGCAGC 155
ApoE-KO Genotyping GCCTAGCCGAGGGAGAGCCG GCCGCCCCGACTGCATCT 245
18 S Real-time PCR GATGCTCTTAGCTGAGTGT GCTCTGGTCCGTCTTG 233
DNT5 Real-time PCR CTCTTCAGTCAGCTGCAGCG TTCTCCGTCTACCGTCAGGG 360
AdipoQ Real-time PCR GTATCGCTCAGCGTTC CGTTGACGTTATCTGCAT 362
Lep Real-time PCR CATTTCACACACGCAGT GGAGGTCTCGGAGATTC 191
Tnfa Real-time PCR CCACCACGCTCTTCTGTCTAC AGGGTCTGGGCCATAGAACT 103
Il6 Real-time PCR TGATGCACTTGCAGAAAACA ACCAGAGGAAATTTTCAATAGGC 109
Il1b Real-time PCR GCAACTGTTCCTGAACTCAACT ATCTTTTGGGGTCCGTCAACT 89
Ccl2/Mcp1 Real-time PCR TGAGTAGGCTGGAGAGCTACAAG TGTATGTCTGGACCCATTCCTTC 126
Ccl3/Mip1a Real-time PCR TGAAACCAGCAGCCTTTGCTC AGGCATTCAGTTCCAGGTCAGTG 125
Ccl5/Rantes Real-time PCR CTCACCATATGGCTCGGACA ACAAACACGACTGCAAGATTGG 126
Ccl7/Mcp3 Real-time PCR GCTGCTTTCAGCATCCAAGTG CCAGGGACACCGACTACTG 135
Srebp1c Real-time PCR GGAGCCATGGATTGCACATT CACTGTCTTGGTTGTTGATGAGCTG 58
Acaca Real-time PCR GCCTCTTCCTGACAAACGAG TGACTGCCGAAACATCTCTG 239
Fasn Real-time PCR GCTGCGGAAACTTCAGGAAAT AGAGACGTGTCACTCCTGGACTT 83
Scd1 Real-time PCR CCCTGCGGATCTTCCTTATC TGTGTTTCTGAGAACTTGTGGTG 103
Table 1. Sequence of primers used for genotyping and real-time PCR.
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H&E staining. Epididymal fat pad and liver tissues were fixed for 48 hr in 4% PFA at 4 °C prior to processing 
on a Leica ASP 200 and embedding in CellWax (Cellpath) on a Leica EG1150H embedding station. Sections 
of 4 μm were cut on a Leica RM2235 microtome onto Plus Frost slides (Solmedia) and allowed to dry at 37 °C 
overnight prior to staining. Slides were de-waxed in xylene and rehydrated in ethanol. H&E was performed by 
staining in Mayer’s Haematoxylin for 2 min and eosin for 2 min. Slides were imaged on an Aperio® AT2 (Leica 
Biosystems) high definition digital pathology slide scanner with a maximal magnification of 20x. Tissue pro-
cessing and imaging were performed at Section of Pathology and Tumour Biology, Leeds Institute of Cancer and 
Pathology. Images were analysed with ImageJ software. Adipocyte size was quantified as the cross-section surface 
area; for each mouse, 2 microscopic fields were analysed and 100 adipocytes per field were measured. Liver stea-
tosis was quantified as the percentage of surface area without staining; for each mouse, 4 microscopic fields were 
analysed.
En face analysis of aorta. Aortae were opened longitudinally, stained with Oil Red O and mounted on a 
coverslip before imaging (Olympus digital camera QICAM on an Olympus SZ61 dissection microscope). Lesion 
area was analysed using Image-Pro Plus 7.0 (Media Cybernetics, Bethesda, MD) in aortic arch (from the heart to 
the end of arch curvature), thoracic and abdominal aorta (from arch terminus to iliac bifurcation).
Plasma lipid analysis. Total blood was collected, without prior fasting, on sodium-citrate from inferior vena 
cava, centrifuged at 13000 g, 4 °C for 10 minutes; plasma was frozen at −80 °C. Analysis was performed by the 
Pathology RD Laboratory at Leeds Teaching Hospitals NHS Trust with a Siemens Advia 2400 device.
Data analysis. Raw data for each parameter are presented in Supplementary File 3. All analyses were per-
formed on a blinded basis. Two statistical approaches were use for data analysis. (1) Data were first analysed for 
Normality and Equality of variances (Origin Pro). As most of the parameters did not satisfy these criteria, data 
were analysed with a Mann-Whitney test. The minimum level of statistical significance considered in the study 
was U < 0.05. Significance is indicated on graphs as follows: #U < 0.05, ##U < 0.01 and ###U < 0.001; U > 0.05 was 
considered non-significant. Data are presented as the mean ± s.e.m. (2) We fitted linear random effects models 
using the statistics package R40 and the nlme library41. Each outcome measure was modelled against the mouse 
group (Control or DNT5) and summarised by 95% confidence intervals for the standardised mean difference 
in outcome measure for DNT5 compared to Control mouse groups. Depending on model convergence, model 
residual diagnostics and model parameter significance, outcome measures were modelled to either include or not 
include: (1) a natural log transformation of the outcome measure; (2) a normally distributed random intercept for 
the cage in which the mice were housed; (3) an identity variance-covariance structure in the normally distributed 
error term that allowed a separate variance inflation factor for each cage in which the mice were housed. Model 
output and model structure definitions for each outcome measure are included in the Supplementary File 4. Data 
are presented as standardised mean difference (red dot) with 95% confidence intervals (vertical black bar), other-
wise mentioned. The minimum level of statistical significance considered in the study was p < 0.05. Significance is 
indicated on graphs as follows: *p < 0.05, **p < 0.01 and ***p < 0.001; p > 0.05 was considered non-significant. 
The number of independent experiments (cages) is indicated by n and the number of mice by N.
Data and Material Availability
All data generated or analysed during this study are included in this published article (and its Supplementary 
Information files). Materials are available on reasonable request.
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